Caricamento...

Delivering on the promise: PARP inhibition as targeted anti-cancer therapy

PURPOSE OF THE REVIEW: Authors present the rationale, clinical development, and current status of Poly (adenosine diphospohate [ADP]) ribose polymerase (PARP) inhibitors (PARPi) as anticancer agents. RECENT FINDINGS: The recent approval of olaparib in heavily pre-treated patients with advanced ovari...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Opin Oncol
Autori principali: Coyne, Geraldine O'Sullivan, Chen, Alice, Kummar, Shivaani
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636335/
https://ncbi.nlm.nih.gov/pubmed/26447876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000238
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !